Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT07193888

Navitor Japan Study

Led by Abbott Medical Devices · Updated on 2025-11-24

100

Participants Needed

1

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Navitor Japan Study is designed to evaluate the safety and performance of the Navitor™ valve used in combination with the FlexNav™ delivery system in a contemporary, real-world setting.

CONDITIONS

Official Title

Navitor Japan Study

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is eligible per the current approved indication after Heart Team discussion and intended to undergo a Navitor TAVI procedure.
  • The patient has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent as approved by the EC of the respective clinical site.
  • The patient and the treating physician agree that the subject will return for all required post-procedure follow-up visits
Not Eligible

You will not qualify if you...

  • Patient is not eligible for the Navitor TAVI System per the current Instructions for Use (IFU).
  • Life expectancy less than 12 months from the time of informed consent due to non-cardiac co-morbid conditions.
  • In the judgment of the Investigator, patient presents with a medical, social, or psychological condition that could limit the ability or willingness to participate in the study, comply with study required testing and/or follow-up visits or that could impact scientific integrity of the study.
  • Known contraindication for computed tomography (CT) or sensitivity to contrast media, which cannot be adequately premedicated.
  • Inability to tolerate antiplatelet/anticoagulation therapy or nitinol alloy (nickel and titanium), which cannot be adequately premedicated.
  • Currently participating in an investigational drug or device study that may confound the results of this study.
  • Anatomy that makes insertion and endovascular access to the aortic valve difficult and/or impossible.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Osaka Keisatsu Hospital

Osaka, Japan

Actively Recruiting

Loading map...

Research Team

B

Bart Janssens

CONTACT

A

Alicia Kimber

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Navitor Japan Study | DecenTrialz